BioCentury
ARTICLE | Financial News

Danish Forward Pharma files for IPO

August 12, 2014 1:21 AM UTC

Forward Pharma A/S (Copenhagen, Denmark) filed to raise up to $200 million in an IPO on NASDAQ underwritten by Leerink Partners. The company expects to trade under the symbol "FWP."

Forward Pharma's lead product is FP187, an oral controlled-release small molecule dimethyl fumarate. The company submitted an IND to FDA for FP187 to treat relapsing-remitting multiple sclerosis (RRMS) and plans to submit the Phase III protocol this quarter. It will begin Phase III trials to treat moderate to severe plaque psoriasis in 2015. ...